1mg, best e pharmacy in India

Human Papillomavirus Type 18 L1Protein



Cervical carcinoma, Human papillomavirus infections.

How it works

Human Papillomavirus (HPV) type 16 and 18 cause about 70% of cervical cancer. HPV bivalent (types 16 and 18) vaccine is a non-infectious vaccine produced by recombinant technology, which contains virus-like particles (VLP) of the major capsid L1 protein of oncogenic HPV types 16 and 18. Efficacy of vaccine may be mediated by the production of IgG neutralizing antibodies against the HPV-L1 capsid proteins.

Common side effects

Dizziness, Fever, Injection site redness, Injection site soreness, Itching, Nausea, Swelling


No medicine available

Content on this page was last updated on 28 September, 2016, by Dr. Varun Gupta (MD Pharmacology)